Skip to main content
. 2017 Nov 16;7:15738. doi: 10.1038/s41598-017-15992-4

Figure 5.

Figure 5

Post-mortem lesions of unknown etiology from cats treated with Maraba virus. Five healthy purpose-bred research cats were vaccinated intramuscularly with 1 × 1010 pfu of an E1/E3-deleted replication-deficient recombinant human serotype 5 adenovirus expressing the tumour-associated antigen human placenta specific 1 (hPLAC1) on day 0. On day 21 cats were boosted by intravenous infusion of 2.5 × 1011 pfu of a replication-competent Maraba virus expressing hPLAC1. On day 39 (i.e. 18 days post-boost), cats were euthanized for post-mortem analysis by a board-certified veterinary pathologist. (a) One cat had evidence of focal coronary arteropathy consisting of a partially thickened arterial wall (arrow). (b) One other cat had mild renal pyelitis with subepithelial infiltration of neutrophils (arrow, upper left panel), focal myocardial fibrosis (arrow, upper right panel), pulmonary congestion (lower left panel) and mild cholangitis (arrow lower right panel).